[Skip to Content]
[Skip to Content Landing]
August 21, 1996

Improved Screening for Prostate Cancer Offers Challenging New Data to Cope With High Incidence

JAMA. 1996;276(7):515-516. doi:10.1001/jama.1996.03540070011005

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


HARDLY ANYONE mistakenly calls that gland the "prostrate" anymore.

Not only is the prostate's name generally being pronounced more accurately, but the discomfort and danger it can pose also are becoming better understood by the public.

A possible near end to both the extra "r" in pronunciation and to public ignorance or reluctance to talk about this sex-related gland appears to be the result of the widespread publicity that the prostate is receiving.

This is particularly true where adenocarcinoma of the prostate is involved. The increasing amount and diversity of research into causes of this cancer have resulted in more articles on prostatic adenocarcinoma in the medical literature in this decade than ever before.

But much more information also is being offered to the public about prostate cancer.

Articles are appearing in many largecirculation magazines and newspapers, as well as in more specifically targeted publications such as health newsletters and